HCP ‘s (HCP) board of directors approved the spinoff of Quality Care Properties, a REIT whose portfolio is comprised of skilled nursing and assisted living facilities. At the time of the spin announcement, Quality Care Properties, which was previously known internally as HCR ManorCare, was expected to own over 320 properties with estimated annual rent of about $485… Read More »
There are a number of spinoffs scheduled to be completed at the end of this month (October) or in early November and naturally, there are a few scheduled changes to the S&P indices as a result. Here is a summary of the changes which will occur over the next week or so: HCP Inc (HCP) is spinning off Quality… Read More »
It’s no surprise that many recently announced spinoffs have been abandoned in favor of outright sales. Possible reasons include the fact that numerous industries are suffering from a lack of organic growth or the fact that these bite size carve out pieces are more easily acquired. Oh yeah, it also helps when acquirers toss around rich valuations. The… Read More »
You may have noticed a lull in our regular programming and for that we apologize. Over the past few weeks, a number of spinoff transactions have closed leading to quite a few shifts within the S&P indices. Here is a summary of the various transactions: Honeywell’s (HON) AdvanSix (ASIX) spinoff was distributed on October 1st and the new company… Read More »
Just months after being spun off from Baxter International(BAX), Baxalta found itself the target of an intense pursuit by Shire Pharmaceuticals(SHPG). Baxalta resisted, but, ultimately agreed to a deal which closed earlier this year. Barron’s sees good things ahead for the combined company. In an article this weekend, the venerable publication points out that merely by achieving a… Read More »
There was much investor chatter last month that Gilead Sciences(GILD) could unlock value by splitting its Hepatitis C business from its HIV business. RBC Capital advanced the case in a note RBC Capital suggested the drugmaker would be better off cutting its businesses right down the middle, saying that shares could jump by as much as 40% if… Read More »
Honeywell’s (HON) board of directors approved the spinoff of AdvanSix, its resin and chemical business. The spinoff will take place on October 1st and shareholders as of September 16th will receive 1 share of AdvanSix for every 25 shares of HON owned. A When-Issued market is expected to be in place beforehand, but post-spin, the company will trade… Read More »
The temperatures remain high, but the summer season is winding down so lets catch up on some news we may have missed. In early August, Emerson Electric (EMR) reached a deal to sell off its network power business to a group led by private equity firm Platinum Equity for the price tag of $4b. The unit generated revenue… Read More »
AbbVie(ABBV) surged out of the gate following its January 2013 spinoff from Abbott Laboratories(ABT). By December 2014, the stock price had doubled. Since then, however, the stock languished, continuing to trade below its December 2014 highs. Despite efforts to diversify, Humira, which is now off patent, accounts for 60% of revenue. Barron’s reports that Raymond James now thinks… Read More »
After pressure from activist firm Engine Capital, CST Brands (CST), a 2013 spinoff from Valero (VLO), announced in early March that it was considering its strategic options. Based on this announcement, Jim Cramer was willing to give his blessing ‘to speculate’ on the name even though it wasn’t ‘exactly what you would call cheap’. While that hardly seemed… Read More »
Shareholders at both Johnson Controls (JCI) and Tyco (TYC) overwhelmingly approved their upcoming merger at their respective special shareholder meetings last week. At JCI, the approval came in the fact of a shareholder lawsuit challenging the company’s executive pay (JCI CEO Alex Molinaroli is making out like a bandit in this deal) and other facets of the deal.… Read More »
BioGen (BIIB) has finally chosen a name for its upcoming hemophilia drug focused spinoff. The new company will be called Bioverativ and it will eventually trade on the Nasdaq under the ticker ‘BIVV’. Bioverativ will be a global biotech company ‘focused on the discovery, research, development and commercialization of treatments for hemophilia and other blood disorders.’ It’s growing… Read More »
Last November, Citrix Systems(CTXS) announced plans to spin off its GoTo business. This week, it announced that the spinoff would culminate in a merger with LogMeIn(LOGM) in a Reverse Morris Trust transaction. The transaction, which is expected to be tax-free, will leave Citrix shareholders owning 50.1% of the new company. LogMeIn’s management team, led by CEO Bill Wagner,… Read More »
ConAgra’s (CAG) planned spinoff of its potato product business, Lamb Weston, is making progress. The most recent milestones achieved were the filing of the company’s initial Form 10 and the naming of its top executives. Thomas Werner, currently President of ConAgra’s Commercial Foods business, will become CEO and Tim McLevish, currently a consultant, will become Executive Chairman. Sean… Read More »
After years of deliberations and studies, Hawaii’s Public Utilities Commission (the ‘HPUC’) recently ruled against NextEra’s (NEE) proposed takeover of local utility Hawaiian Electric (HE). The commission concluded that NextEra ‘failed to prove its plans for HECO would be good for the state’ and it wasn’t convinced it would ultimately benefit Hawaii’s consumers. A big sticking point appeared… Read More »